Managing type 2 diabetes mellitus involves maintaining appropriate blood glucose levels through a combination of medication, healthy eating, physical activity and regular medical monitoring. Depending on an individual’s condition and treatment requirements, healthcare professionals may prescribe medicines containing different active ingredients to support glycaemic control. Sitacure M 50 / 500 is one such combination medicine containing Sitagliptin and Metformin and may be prescribed when combination therapy is considered appropriate.
Sitacure-M 50/500
Sitacure-M 50/500 contains Sitagliptin 50mg and Metformin Hydrochloride 500mg. It is an oral antidiabetic medicine intended for use in adults with type 2 diabetes mellitus under the direction of a qualified healthcare professional. The two active ingredients have different mechanisms of action and can provide complementary effects on blood glucose regulation.
Treatment with Sitacure-M 50/500 should form part of an individualized diabetes management plan. Medication may be combined with dietary changes, physical activity and regular monitoring according to the recommendations of a doctor or other healthcare professional.
Composition of Sitacure-M 50/500
Each tablet contains two active pharmaceutical ingredients:
Sitagliptin 50mg
Sitagliptin belongs to a class of medicines known as DPP-4 inhibitors. It works by affecting incretin hormones involved in blood glucose regulation. Its action helps support glucose-dependent insulin release and helps regulate glucagon levels.
Metformin Hydrochloride 500mg
Metformin belongs to the biguanide class of antidiabetic medicines. It primarily works by reducing glucose production by the liver and improving the body’s sensitivity to insulin. It is widely used as part of treatment strategies for type 2 diabetes mellitus.
Uses of Sitacure-M 50/500
Sitacure-M 50/500 may be prescribed to help improve glycaemic control in adults with type 2 diabetes mellitus when Sitagliptin and Metformin combination therapy is considered suitable.
It may be incorporated into a broader treatment plan involving:
- Appropriate dietary management
- Regular physical activity
- Blood glucose monitoring
- Regular medical follow-up
- Individualized medication management
The exact treatment approach depends on factors such as the patient’s medical history, current blood glucose control, kidney function and previous diabetes medicines.
How Does Sitacure-M 50/500 Work?
The two components of Sitacure-M 50/500 work through different mechanisms.
Sitagliptin inhibits the DPP-4 enzyme, helping increase the activity of incretin hormones when blood glucose levels are elevated. This supports glucose-dependent insulin secretion and helps regulate glucagon production.
Metformin primarily reduces hepatic glucose production and improves insulin sensitivity. By combining these mechanisms, the medicine can be used when a healthcare professional considers both components appropriate for the patient’s diabetes treatment plan.
Sitacure-M 50/500 and Other Sitacure Products
Hertz Pharma offers different Sitacure formulations intended for specific treatment requirements. Sitacure 100 contains Sitagliptin 100mg and may be prescribed when Sitagliptin therapy is considered appropriate. Another formulation, Sitacure D 10/100, combines Dapagliflozin 10mg with Sitagliptin 100mg.
These products should not be considered interchangeable simply because they belong to the same product range. Their active ingredients, strengths and therapeutic considerations differ. A healthcare professional should determine which medicine and dosage are appropriate for an individual patient.
Dosage and Administration
The dosage of Sitacure-M 50/500 should always be determined by a qualified healthcare professional. Treatment decisions may depend on previous diabetes therapy, current glycaemic control, kidney function, tolerability and other medical conditions.
Patients should follow the prescribed dosage and administration instructions carefully. Do not increase, reduce or discontinue the medicine without first consulting a doctor. Taking the medicine as prescribed and attending recommended follow-up appointments can help support appropriate diabetes management.
Possible Side Effects
Like other medicines, Sitacure-M 50/500 may cause side effects in some individuals. Metformin-containing medicines may commonly be associated with gastrointestinal symptoms, particularly during treatment initiation.
Possible symptoms may include:
- Nausea
- Diarrhoea
- Stomach discomfort
- Reduced appetite
- Headache
If symptoms are severe, persistent or concerning, patients should contact their healthcare professional for advice.
Warnings and Precautions
Before starting Sitacure-M 50/500, patients should inform their doctor about existing medical conditions and all medicines, vitamins and supplements they use. Particular attention may be required in people with kidney problems, liver conditions, heart-related conditions or a history of pancreatitis.
Kidney function is especially important when using Metformin-containing medicines. A healthcare professional may assess renal function before treatment and periodically during therapy when clinically appropriate.
Sitagliptin-containing medicines have been associated with reports of acute pancreatitis. Severe or persistent abdominal pain should therefore be discussed promptly with a healthcare professional.
Metformin is also associated with a rare but serious condition called lactic acidosis. The risk can increase in certain medical circumstances, including significant impairment of kidney function. Medical advice should be obtained before starting or continuing treatment when relevant risk factors are present.
Drug Interactions and Monitoring
Patients should tell their healthcare professional about all prescription medicines, over-the-counter medicines, supplements and vitamins they are taking. Certain medicines can affect blood glucose levels, kidney function or the safety of diabetes treatment.
Regular monitoring may help healthcare professionals assess treatment response and determine whether adjustments are required. Patients should attend scheduled appointments and follow recommended blood glucose monitoring instructions.
Storage Information
Sitacure-M 50/500 should be stored according to the conditions provided on the product packaging. Keep the tablets protected from excessive heat, moisture and direct sunlight, and keep them out of the reach of children. The medicine should remain in its original packaging until use.
Conclusion
Sitacure M 50 / 500 combines Sitagliptin 50mg with Metformin Hydrochloride 500mg and may be used as part of an individualized treatment plan for adults with type 2 diabetes mellitus. Sitacure 100 and Sitacure D 10/100 are other formulations within the Sitacure range, but their compositions and treatment considerations are different. The choice of medicine should always be made by a qualified healthcare professional based on the patient’s individual medical needs. Hertz Pharma focuses on providing pharmaceutical products that can support appropriate treatment and responsible diabetes care.